Article Details

ImmunoPrecise Antibodies : Partners on Launch of SARS-CoV-2 Nanomedicine Therapy Program

Retrieved on: 2021-01-18 16:40:44

Tags for this article:

Click the tags to see associated articles and topics

ImmunoPrecise Antibodies : Partners on Launch of SARS-CoV-2 Nanomedicine Therapy Program. View article details on hiswai:

Excerpt

... further as this antibody-based nanomedicine format is hypothesized to have additional therapeutic benefits compared to single monoclonal antibody ...

Article found on: www.marketscreener.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up